PT - JOURNAL ARTICLE AU - Njoroge, George AU - Mwenda, Catherine AU - Mecha, Ezekiel AU - Waithaka, Stanley TI - ALCOHOLIC LIVER BIOMARKERS: DETERMINANTS FOR ADMISSION TO REHABILITATION CENTRES DURING THE COVID 19 PERIOD IN KENYA AID - 10.1101/2022.10.18.22281212 DP - 2022 Jan 01 TA - medRxiv PG - 2022.10.18.22281212 4099 - http://medrxiv.org/content/early/2022/10/20/2022.10.18.22281212.short 4100 - http://medrxiv.org/content/early/2022/10/20/2022.10.18.22281212.full AB - Consumption of alcohol is a practice world over that dates back to 10,000 Before Christ. Evaluation on the damages caused by the alcohol on the human organs such as the liver is paramount. There is no direct evaluation to liver parenchyma before admission rather blood samples are evaluated to show damage or no damage to the liver cells. The outcome of the blood samples denote the health status of the liver cells before admission. Alcohol biomarkers are usually elevated when there is damage to the liver parenchyma. This was a quantitative descriptive cross sectional study. Purpose sampling was used to select two Counties with the highest number of alcohol consumers. Simple Random sampling method was used to select participants for liver biomarkers. Participants were requested to consent for blood donation and confidentiality was maintained. Blood samples collected were separated for serum and cells using centrifuge within one hour after donation. The samples were transported for storage using cool boxes and temperature was maintained between −8 and +8 degrees during transportation. The blood samples were stored at −8 and +8 degrees in the deep freezer. Majority (97%) of the participants had alanine aminotransferase levels of 41 to 80 IU/L. Eighty eight percent of the participants had aspartate aminotransferase elevated to between 35 and 68 IU/L. Gamma Glutamyl aminotransferase was elevated in all of the participants while alanine phosphatase was elevated in 99% of the participants. Most participants had elevated liver biomarkers before admission to rehabilitation centre.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval granted by Mount Kenya University Institutional Scientific Ethics Review Committee. No.-865I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsList of abbreviationsADHAlcohol DehydrogenaseALDAlcoholic liver DiseaseALDHAldehyde DehydrogenaseALIAlcoholic Liver InjuryALTAlanine AminotransferaseALPAlkaline PhosphataseASTAspartate AminotransferaseAUDAlcohol Use DisorderBCBefore ChristCDTCarbohydrate Deficient TransferinEASLEuropean Association for the Study of LiverGGTGamma-Glutamyl TransferaseIU/LInternational Units per LitreIUInternational UnitsLFTLiver Function TestsMKUMount Kenya UniversityNACADANational Alcohol and Drug AbuseNACOSTINational Commission for Science, Technology and InnovationNALDNon Alcoholic Liver DiseasePEthPhosphatydilethanolSPSSStatistical Package for Social ScienceUKUnited KingdomUSUnited StatesUSAUnited State of AmericaWHOWorld Health Organization